HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subcutaneous implantable cardioverter-defibrillator: Initial experience.

AbstractBACKGROUND:
Implantable cardioverter-defibrillators (ICDs) are important tools in the prevention of sudden death, but implantation requires transvenous access, which is associated with complications. Subcutaneous implantable cardioverter-defibrillators (S-ICDs) may prevent some of these complications.
AIM:
To evaluate the therapeutics and complications associated with S-ICD systems.
METHODS:
S-ICD implantation was planned in 23 patients, for whom the indications were vascular access problems, increased risk of infection or young patients with long predicted follow-up. The population consisted of four patients with ischemic heart disease, three of them on hemodialysis (two with subclavian vein thrombosis), five with left ventricular noncompaction, four with Brugada syndrome, three with arrhythmogenic right ventricular cardiomyopathy, one with transposition of the great vessels, two with dilated cardiomyopathy and four with hypertrophic cardiomyopathy.
RESULTS:
S-ICDs were implanted in 21 patients, two having failed to fulfil the initial screening criteria. Mean implantation time was 77 minutes, with no complications. Defibrillation tests were performed, and in one patient the generator had to be repositioned to obtain an acceptable threshold. In a mean follow-up of 14 months, 10 patients had S-ICD shocks, which were appropriate in half of them; one developed infection, one needed early replacement due to loss of telemetry and one patient died of noncardiac cause.
CONCLUSIONS:
S-ICD implantation can be performed by cardiologists with a high success rate. Initial experience appears favorable, but further studies are needed with longer follow-up times to assess the safety and efficacy of this strategy compared to conventional devices.
AuthorsPedro Galvão, Diogo Cavaco, Pedro Adragão, Francisco Costa, Pedro Carmo, Francisco Morgado, Ricardo Bernardo, Manuela Nunes, Miguel Abecasis, José Neves, Miguel Mendes
JournalRevista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology (Rev Port Cardiol) Vol. 33 Issue 9 Pg. 511-7 (Sep 2014) ISSN: 2174-2030 [Electronic] Portugal
PMID25242675 (Publication Type: Journal Article)
CopyrightCopyright © 2013 Sociedade Portuguesa de Cardiologia. Published by Elsevier España. All rights reserved.
Topics
  • Adolescent
  • Adult
  • Aged
  • Arrhythmogenic Right Ventricular Dysplasia (therapy)
  • Brugada Syndrome (therapy)
  • Cardiomegaly (therapy)
  • Cardiomyopathy, Dilated (therapy)
  • Death, Sudden, Cardiac (prevention & control)
  • Defibrillators, Implantable
  • Female
  • Follow-Up Studies
  • Heart Diseases (complications, therapy)
  • Humans
  • Male
  • Middle Aged
  • Myocardial Ischemia (therapy)
  • Operative Time
  • Renal Dialysis
  • Transposition of Great Vessels (therapy)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: